Published in Nat Neurosci on April 25, 2016
EGFRvIII: the promiscuous mutation. Cell Death Discov (2016) 0.85
Old player, new partner: EGFRvIII and cytokine receptor signaling in glioblastoma. Nat Neurosci (2016) 0.75
Role of STAT3 in Genesis and Progression of Human Malignant Gliomas. Mol Neurobiol (2016) 0.75
Targeting OSMR in glioma stem cells. Oncotarget (2017) 0.75
Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression. Proc Natl Acad Sci U S A (2017) 0.75
A TNF-JNK-Axl-ERK signaling axis mediates primary resistance to EGFR inhibition in glioblastoma. Nat Neurosci (2017) 0.75
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (2005) 74.55
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res (2008) 54.83
Identification of human brain tumour initiating cells. Nature (2004) 38.87
Identification of a cancer stem cell in human brain tumors. Cancer Res (2003) 24.02
Malignant gliomas in adults. N Engl J Med (2008) 20.54
Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev (2007) 17.20
GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol (2010) 16.72
MEME: discovering and analyzing DNA and protein sequence motifs. Nucleic Acids Res (2006) 15.32
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res (2004) 14.73
FIMO: scanning for occurrences of a given motif. Bioinformatics (2011) 8.89
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci (2007) 7.77
Malignant glioma: genetics and biology of a grave matter. Genes Dev (2001) 6.78
Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci U S A (1992) 6.58
Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci (2007) 6.08
Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell (2002) 5.11
Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene (2004) 4.29
Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science (1997) 4.26
Molecular pathology of malignant gliomas. Annu Rev Pathol (2006) 4.24
Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes Dev (2010) 3.99
A molecular network for de novo generation of the apical surface and lumen. Nat Cell Biol (2010) 3.70
Statistics review 12: survival analysis. Crit Care (2004) 3.29
Gliomagenesis: genetic alterations and mouse models. Nat Rev Genet (2001) 3.13
Essential role of STAT3 for embryonic stem cell pluripotency. Proc Natl Acad Sci U S A (1999) 2.74
Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. Genes Dev (2008) 2.61
Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. Cancer Res (2002) 2.45
Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity. Cancer Res (2003) 2.30
EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma. Cancer Cell (2013) 2.28
Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens. Stem Cells (2009) 1.96
Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem (1996) 1.89
An in vivo patient-derived model of endogenous IDH1-mutant glioma. Neuro Oncol (2011) 1.70
Predominant expression of mutant EGFR (EGFRvIII) is rare in primary glioblastomas. Brain Pathol (2004) 1.59
Snail regulates MyoD binding-site occupancy to direct enhancer switching and differentiation-specific transcription in myogenesis. Mol Cell (2012) 1.46
Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. J Neurosci (2008) 1.36
Transcriptional dominance of Pax7 in adult myogenesis is due to high-affinity recognition of homeodomain motifs. Dev Cell (2012) 1.23
STAT3 regulation of glioblastoma pathogenesis. Curr Mol Med (2009) 1.13
Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications. Cancer Lett (2001) 1.11
Therapeutic advances for glioblastoma multiforme: current status and future prospects. Curr Oncol Rep (2007) 1.09
Interaction of Hsp90 with the nascent form of the mutant epidermal growth factor receptor EGFRvIII. J Biol Chem (2002) 1.00
Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma. J Pathol (2014) 0.91
iNOS: a potential therapeutic target for malignant glioma. Curr Mol Med (2013) 0.89
Overexpression of the oncostatin M receptor in cervical squamous cell carcinoma cells is associated with a pro-angiogenic phenotype and increased cell motility and invasiveness. J Pathol (2011) 0.87
STAT3-iNOS Signaling Mediates EGFRvIII-Induced Glial Proliferation and Transformation. J Neurosci (2012) 0.87
EGFR and EGFRvIII in glioblastoma: partners in crime. Cancer Cell (2013) 0.86
Chromatin tandem affinity purification sequencing. Nat Protoc (2013) 0.78